These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27837158)

  • 1. Development of a Quality-of-Life Measure for Hidradenitis Suppurativa.
    Sisic M; Kirby JS; Boyal S; Plant L; McLellan C; Tan J
    J Cutan Med Surg; 2017; 21(2):152-155. PubMed ID: 27837158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary Validation of the HS-QoL: A Quality-of-Life Measure for Hidradenitis Suppurativa.
    McLellan C; Sisic M; Oon HH; Tan J
    J Cutan Med Surg; 2018; 22(2):142-146. PubMed ID: 28992738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.
    Kimball AB; Sundaram M; Banderas B; Foley C; Shields AL
    J Dermatolog Treat; 2018 Mar; 29(2):152-164. PubMed ID: 28608738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
    Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
    Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.
    Sampogna F; Fania L; Mazzanti C; Caggiati A; Pallotta S; Panebianco A; Mastroeni S; Didona B; Pintori G; Abeni D
    Dermatology; 2019; 235(4):308-314. PubMed ID: 31121589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.
    Kirby JS; Thorlacius L; Villumsen B; Ingram JR; Garg A; Christensen KB; Butt M; Esmann S; Tan J; Jemec GBE
    Br J Dermatol; 2020 Aug; 183(2):340-348. PubMed ID: 31705538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument.
    Thorlacius L; Esmann S; Miller I; Vinding G; Jemec GBE
    Skin Appendage Disord; 2019 Jun; 5(4):221-229. PubMed ID: 31367600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Comprehensive Quality-of-Life Measure for Facial and Torso Acne.
    McLellan C; Frey MP; Thiboutot D; Layton A; Chren MM; Tan J
    J Cutan Med Surg; 2018; 22(3):304-311. PubMed ID: 29383947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa.
    Marrón SE; Gómez-Barrera M; Tomás-Aragonés L; Díaz Díaz RM; Vilarrasa Rull E; Madrid Álvarez MB; Puig L
    Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):554-560. PubMed ID: 31023484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life in Cohabitants of Patients with Hidradenitis Suppurativa: A Cross-sectional Study.
    Ramos-Alejos-Pita C; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Three-Item Skindex-Mini Among Hidradenitis Suppurativa Patients With Diverse Racial Backgrounds.
    Orenstein LAV; Amah A; Shaw FM; Zhang C; Swerlick RA; Chen SC
    J Cutan Med Surg; 2020; 24(5):457-460. PubMed ID: 32469259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected].
    Patel ZS; Hoffman LK; Buse DC; Grinberg AS; Afifi L; Cohen SR; Lowes MA; Seng EK
    Curr Pain Headache Rep; 2017 Nov; 21(12):49. PubMed ID: 29094219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Image Quality of Life in Patients with Hidradenitis Suppurativa Compared with Other Dermatological Disorders.
    Andersen PL; Nielsen RM; Sigsgaard V; Jemec GBE; Riis PT
    Acta Derm Venereol; 2020 Apr; 100(8):adv00107. PubMed ID: 32201901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
    Peris K; Lo Schiavo A; Fabbrocini G; Dini V; Patrizi A; Fusano M; Bianchi L; Guanziroli E; Guarneri C; Parodi A; Bertoldi A; Musumeci ML; Offidani A; Rongioletti F; Pistone G; Malara G; Potenza C; Casari A; Franchi C; Ardigò M; Cusano F; Stingeni L; Amerio P; Mancini LL; Prignano F; Deboli T; Gualberti G; Saragaglia V; Bettoli V
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):766-773. PubMed ID: 30633405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life of Patients With Pyoderma Gangrenosum and Hidradenitis Suppurativa.
    Gerard AJ; Feldman SR; Strowd L
    J Cutan Med Surg; 2015; 19(4):391-6. PubMed ID: 25775617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study.
    Janse IC; Deckers IE; van der Maten AD; Evers AWM; Boer J; van der Zee HH; Prens EP; Horváth B
    Br J Dermatol; 2017 Apr; 176(4):1042-1047. PubMed ID: 27534591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
    Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa.
    Kouris A; Platsidaki E; Christodoulou C; Efstathiou V; Dessinioti C; Tzanetakou V; Korkoliakou P; Zisimou C; Antoniou C; Kontochristopoulos G
    Dermatology; 2016; 232(6):687-691. PubMed ID: 28052274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.